FDA Approved 503B Outsourcing Facility
RXQ Compounding, LLC manufactures sterile and non-sterile medications, including products that are on the FDA Short List. We provide these medications to physician offices and hospitals across the United States. RXQ Compounding, LLC is currently licensed to ship to 35 states and Washington, DC, while rapidly acquiring licenses for other states. RXQ must comply with Current Good Manufacturing Practice (CGMP) guidelines and US Pharmacopeia Guidelines (USP), and we are subject to risk-based inspections by the Federal Drug Administration at any time. Our products do not require a patient prescription and can be used for office use. As an FDA 503B Outsourcing Facility, we are required by the FDA to follow strict testing standards for sterility, potency, and endotoxins. Our products are compounded in ISO 5 clean rooms that are continuously monitored for particulate matter and environmental conditions. RXQ Compounding, LLC emerged in front of new regulations from the FDA governing compounding facilities and the state board of pharmacy to assure the safest products are delivered to our customers and patients. Guarantee safety, availability, and compliance by making RXQ Compounding, LLC your FDA 503B Outsourcing Facility. For more information, please visit us online at www.RXQCompounding.com or call us directly at (866) 280-0031.
CONTACT INFORMATION:
RXQ Compounding, LLC
340 West State Street Unit 9
Athens, OH 45701
TOLL-FREE: 866-280-0031
FAX: 740-994-2887
info@RXQCompounding.com
